about
In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir.Parenteral bilirubin in healthy volunteers: a reintroduction in translational research.Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.Urinalysis of MMX-mesalazine as a tool to monitor 5-ASA adherence in daily IBD practice.Large differences in neonatal drug use between NICUs are common practice: time for consensus?Safe use of proton pump inhibitors in patients with cirrhosis.A pharmacological rationale for improved everolimus dosing in oncology and transplant patientsCobicistat: A case of mislabelled drug-drug interaction risk?Effectiveness of medication review on the number of drug-related problems in patients visiting the outpatient cardiology clinic: A randomized controlled trialViral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 UpdateReview article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation - implications for maternal dosing, foetal exposure, and safety for mother and childCOVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions
P50
Q40097071-0391E7DF-5B69-4790-948B-54E4B777831BQ47723171-20928675-DF19-44D6-AFDB-50CE266640A9Q48109856-87E60A9E-6D9E-4DFA-B304-072F97FD70ABQ48122081-346D2C3D-B693-4F14-BACC-CA4510279599Q54240649-30A50850-5D1E-4B6F-A182-7B26F45056B0Q55718075-10BC4351-850B-4894-8BEE-C2BD3E6E24C6Q88161774-D57F2EB4-1400-46A4-ADCB-DB308C2D9E61Q90123442-0AF67AB0-B40E-41BE-8424-6EC2AA26E39AQ90994556-2E32E910-F634-4012-A552-F5FB5F9A3A69Q92203399-4832172E-1F4E-4B0E-A8AE-306700CED757Q92861354-B7607190-363C-4321-A5B2-0408830A369DQ94563940-7BA0062F-AD8A-4CF1-A2B0-46D4B8850268
P50
description
researcher
@en
name
D M Burger
@en
type
label
D M Burger
@en
prefLabel
D M Burger
@en
P31
P496
0000-0001-7279-2818